Quick Answer
Semnur Pharmaceuticals, Inc. reported Stockholders Equity of -$20.75 million for fiscal year 2025.
Semnur Pharmaceuticals, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$20.75M | +51.5% |
| 2024 | -$42.78M | -12.3% |
| 2023 | -$38.09M | -1064.5% |
| 2022 | -$3.27M | — |
| 2021 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$14.59M | +65.3% | +67.2% |
| June 30, 2025 | -$44.45M | -9.2% | -2.3% |
| March 31, 2025 | -$43.45M | -9.7% | -1.6% |
| December 31, 2024 | -$42.78M | -12.3% | -1.8% |
| September 30, 2024 | -$42.01M | -429.6% | -3.2% |
| June 30, 2024 | -$40.71M | -518.1% | -2.8% |
| March 31, 2024 | -$39.60M | -662.6% | -4.0% |
| December 31, 2023 | -$38.09M | -1064.5% | -380.3% |
- Semnur Pharmaceuticals, Inc. showed an increase of +51.5% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from Semnur Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: